Markets:

Overview

News

Currencies

International

Treasuries

Danaher Corp (NY:DHR)

229.10 -1.57 (-0.68%)

Streaming Delayed Price Updated: 3:53 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9

...

26 27 Next >

Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company ↗

January 28, 2025

Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds.

Via Benzinga

Topics Energy

3 Insanely Cheap Stocks to Buy ↗

January 25, 2025

The object is to buy low and sell high.

Via The Motley Fool

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications

January 21, 2025

From Aldevron

Via Business Wire

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

January 15, 2025

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗

January 02, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

December 24, 2024

Via Benzinga

14 Analysts Have This To Say About Danaher ↗

December 23, 2024

Via Benzinga

5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead ↗

December 20, 2024

Dan S. Loeb, founder of Third Point, a $7B hedge fund, is known for bold activist strategies that drive transformation in global companies.

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 13, 2024

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and the reasons why the stocks may be drawing attention.

Via Benzinga

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst ↗

December 13, 2024

BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 05, 2024

Via Benzinga

What the Options Market Tells Us About Danaher ↗

November 20, 2024

Via Benzinga

What the Options Market Tells Us About Danaher ↗

November 15, 2024

Via Benzinga

Peering Into Danaher's Recent Short Interest ↗

November 04, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 29, 2024

Via Benzinga

Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry ↗

November 04, 2024

Via Benzinga

A Look Into Danaher Inc's Price Over Earnings ↗

November 01, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today ↗

October 28, 2024

Via Benzinga

Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks. ↗

October 26, 2024

These seven companies are transforming steady profits into rising passive income streams for investors.

Via The Motley Fool

Critical Insights From Danaher Analyst Ratings: What You Need To Know ↗

October 23, 2024

Via Benzinga

A Closer Look at Danaher's Options Market Dynamics ↗

October 22, 2024

Via Benzinga

Earnings Preview: Danaher ↗

October 21, 2024

Via Benzinga

This Is What Whales Are Betting On Danaher ↗

October 16, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

October 14, 2024

Via Benzinga

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating ↗

October 22, 2024

Danaher posts Q3 sales of $5.79 billion, surpassing expectations. 2024 guidance includes bioprocessing revenue decline and Cepheid respiratory sales of $1.7 billion.

Via Benzinga

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday? ↗

October 22, 2024

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election just two weeks away. Concerns over U.S. fiscal policies and...

Via Benzinga

Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance ↗

October 22, 2024

Danaher posted third-quarter sales of $5.8 billion, surpassing expectations, with growth in life sciences and diagnostics segments, and a 27.5% operating margin.

Via Benzinga

Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential' ↗

October 18, 2024

Hedge fund manager Daniel Loeb is optimistic about the economy and market and he sees Trump likely retaking White House.

Via Benzinga

Topics Economy Government

Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR). ↗

October 16, 2024

The technical analysis for DANAHER CORP (NYSE:DHR) is highly positive, with a rating of 8 out of 10, suggesting a potential breakout.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.